These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 299848)

  • 1. Effects of cycloleucine on macrophages and on experimental allergic encephalomyelitis.
    Levine S; Sowinski R
    Exp Mol Pathol; 1977 Feb; 26(1):103-12. PubMed ID: 299848
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of experimental allergic encephalomyelitis by transfer of lymph node cells from Lewis rats pretreated with complete Freund's adjuvant.
    Englert D; Hempel K
    Int Arch Allergy Appl Immunol; 1981; 66(3):326-31. PubMed ID: 6170593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the refractoriness to reinduction of experimental allergic encephalomyelitis in Lewis rats that have recovered from one episode of the disease.
    MacPhee IA; Mason DW
    J Neuroimmunol; 1990 Apr; 27(1):9-19. PubMed ID: 1690754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of self tolerance in experimental allergic encephalomyelitis. I. Differences between lymph node and spleen suppressor cells.
    Welch AM; Swierkosz JE; Swanborg RH
    J Immunol; 1978 Nov; 121(5):1701-5. PubMed ID: 309479
    [No Abstract]   [Full Text] [Related]  

  • 5. Transfer of allergic encephalomyelitis with spleen cells from donors sensitized with myelin basic protein in incomplete Freund's adjuvant.
    Namikawa T; Richert JR; Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1982 Feb; 128(2):932-4. PubMed ID: 6172517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental allergic encephalomyelitis in the Lewis rat: studies on the mechanism of recovery from disease and acquired resistance to reinduction.
    Willenborg DO
    J Immunol; 1979 Sep; 123(3):1145-50. PubMed ID: 313947
    [No Abstract]   [Full Text] [Related]  

  • 7. Regulation of experimental allergic encephalomyelitis. III. Demonstration of effector cells in tolerant rats.
    Holda JH; Swanborg RH
    Eur J Immunol; 1981 Apr; 11(4):338-40. PubMed ID: 6166483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental allergic encephalomyelitis: changes in growth and proliferation within the draining lymph node following injection of basic encephalitogenic protein in Freund's complete adjuvant.
    Matous-Malbohan I; Holub M; Krásenská J; Marĕs V; Lodin Z
    Cell Immunol; 1974 Jun; 12(3):350-62. PubMed ID: 4142422
    [No Abstract]   [Full Text] [Related]  

  • 9. Regulation of paralytic experimental allergic encephalomyelitis in rats: susceptibility to active and passive disease reinduction.
    Hinrichs DJ; Roberts CM; Waxman FJ
    J Immunol; 1981 May; 126(5):1857-62. PubMed ID: 6163820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of clonixin and betamethasone on adjuvant-induced arthritis and experimental allergic encephalomyelitis in rats.
    Watnick AS; Sabin C
    Jpn J Pharmacol; 1972 Dec; 22(6):741-8. PubMed ID: 4541481
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic relapsing experimental allergic encephalomyelitis in the Lewis rat: studies on immune regulation.
    Chow LH; Feurer C; Borel JF
    J Neuroimmunol; 1988 Oct; 19(4):329-38. PubMed ID: 3049665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucosteroids in immunologically specific and nonspecific inflammatory processes.
    Kowalczyk-Bronisz SH
    Arch Immunol Ther Exp (Warsz); 1972; 20(4):577-605. PubMed ID: 4562366
    [No Abstract]   [Full Text] [Related]  

  • 13. Adoptive transfer of experimental allergic encephalomyelitis: incubation of rat spleen cells with specific antigen.
    Richert JR; Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1979 Feb; 122(2):494-6. PubMed ID: 84024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of experimental allergic encephalomyelitis. Part 4. Further characterization of postrecovery suppressor cells.
    Killen JA; Swanborg RH
    J Neuroimmunol; 1982 Oct; 3(2):159-66. PubMed ID: 6181092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of cellular factors in the pathogenesis of experimental allergic encephalomyelitis].
    Kantchourine AK; Posina IM
    Rev Immunol Ther Antimicrob; 1969; 33(3):111-8. PubMed ID: 5799851
    [No Abstract]   [Full Text] [Related]  

  • 16. Autoimmune effector cells. IV. Induction of experimental allergic encephalomyelitis in Lewis rats without adjuvant.
    Holda JH; Silberg D; Swanborg RH
    J Immunol; 1983 Feb; 130(2):732-4. PubMed ID: 6184402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular and genetic basis of the relative resistance to the induction of experimental allergic encephalomyelitis (EAE) in albino oxford (AO) rats.
    Mostarica-Stojkovic M; Petrovic M; Lukic ML
    Adv Exp Med Biol; 1982; 149():699-702. PubMed ID: 6216773
    [No Abstract]   [Full Text] [Related]  

  • 18. The presence of specific antigen-reactive cells during the induction, recovery, and resistance phases of experimental allergic encephalomyelitis.
    Waxman FJ; Fritz RB; Hinrichs DJ
    Cell Immunol; 1980 Jan; 49(1):34-42. PubMed ID: 6153156
    [No Abstract]   [Full Text] [Related]  

  • 19. Further studies on the inhibition of allergic encephalomyelitis by L-asparaginase.
    Khan A; Levine S
    J Immunol; 1974 Jul; 113(1):367-70. PubMed ID: 4134065
    [No Abstract]   [Full Text] [Related]  

  • 20. Activation of effector cells in experimental allergic encephalomyelitis by interleukin 2 (IL-2).
    Ortiz-Ortiz L; Weigle WO
    J Immunol; 1982 Apr; 128(4):1545-50. PubMed ID: 6174605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.